Contrast-associated Acute Kidney Injury in Patients With Different Types of Coronary Artery Disease
NCT ID: NCT04163484
Last Updated: 2024-10-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
156 participants
OBSERVATIONAL
2019-01-15
2024-05-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prevention of Contrast Induced Nephropathy in Patients With Advanced Renal Dysfunction Undergoing Coronary Interventions
NCT02468401
Effectiveness of Remote Ischemic Preconditioning for Prevention of Contrast Induced Acute Kidney Injury in Patients Undergoing Coronary Angiograms.
NCT05147831
Prevention of Contrast-induced Nephropathy in Patients With Acute Myocardial Infarction
NCT01160627
Contrast-medium Induced Nephrotoxicity in Patients Undergoing Coronary Angiography - Iodixanol Versus Iopromide
NCT00823628
Biochemical Effects of Remote Ischemic Pre-Conditioning on Contrast-induced Acute Kidney Injury
NCT03236441
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Stable coronary artery disease
Iodinated contrast
Intra-arterial injection of iodinated contrast media during percutaneous coronary intervention
ST-elevation myocardial infarction
Iodinated contrast
Intra-arterial injection of iodinated contrast media during percutaneous coronary intervention
Non-ST-elevation myocardial infarction
Iodinated contrast
Intra-arterial injection of iodinated contrast media during percutaneous coronary intervention
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Iodinated contrast
Intra-arterial injection of iodinated contrast media during percutaneous coronary intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Stable CAD receiving optimal medical treatment requiring PCI or STEMI or NSTEMI
* Intra-arterial injection of iodinated contrast media
* Informed consent
Exclusion Criteria
* Pregnancy, lactation
* Refuse to sign the informed consent
* Contraindications for PCI
* Other conditions affecting prognosis (oncology, liver failure etc)
* CKD stage 4-5
* Patients receiving nephrotoxic drugs
18 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
I.M. Sechenov First Moscow State Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Olga Mironova
MD PhD Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Olga Mironova, MD PhD
Role: STUDY_DIRECTOR
I. M. Sechenov First Moscow State Medical University (Sechenov University)
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Sechenov University
Moscow, , Russia
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
Kuznetsov VA, Mironova OIu, Gritsanchuk AM, Fomin VV. Contrast-associated acute kidney injury after percutaneous coronary interventions in patients with acute coronary syndrome: a real-world study. Consilium Medicum. 2022;24(10):713-717
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
11/2019
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.